 | • レポートコード：QY2207C3843 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のブロムヘキシン錠の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にブロムヘキシン錠の世界市場のxxx％を占める「8mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「慢性気管支炎」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のブロムヘキシン錠の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのブロムヘキシン錠市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのブロムヘキシン錠市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ブロムヘキシン錠のグローバル主要メーカーには、Sanofi、Teva、Boehringer Ingelheim、Novartis、Mylan、GSK、Mayne Pharma、Abbottなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ブロムヘキシン錠市場は、種類と用途によって区分されます。世界のブロムヘキシン錠市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 8mg、その他 【用途別セグメント】 慢性気管支炎、喘息、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ブロムヘキシン錠製品概要 - 種類別市場（8mg、その他） - 用途別市場（慢性気管支炎、喘息、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のブロムヘキシン錠販売量予測2017-2028 - 世界のブロムヘキシン錠売上予測2017-2028 - ブロムヘキシン錠の地域別販売量 - ブロムヘキシン錠の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ブロムヘキシン錠販売量 - 主要メーカー別ブロムヘキシン錠売上 - 主要メーカー別ブロムヘキシン錠価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（8mg、その他） - ブロムヘキシン錠の種類別販売量 - ブロムヘキシン錠の種類別売上 - ブロムヘキシン錠の種類別価格 ・用途別市場規模（慢性気管支炎、喘息、その他） - ブロムヘキシン錠の用途別販売量 - ブロムヘキシン錠の用途別売上 - ブロムヘキシン錠の用途別価格 ・北米市場 - 北米のブロムヘキシン錠市場規模（種類別、用途別） - 主要国別のブロムヘキシン錠市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのブロムヘキシン錠市場規模（種類別、用途別） - 主要国別のブロムヘキシン錠市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のブロムヘキシン錠市場規模（種類別、用途別） - 主要国別のブロムヘキシン錠市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のブロムヘキシン錠市場規模（種類別、用途別） - 主要国別のブロムヘキシン錠市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのブロムヘキシン錠市場規模（種類別、用途別） - 主要国別のブロムヘキシン錠市場規模（トルコ、サウジアラビア） ・企業情報 Sanofi、Teva、Boehringer Ingelheim、Novartis、Mylan、GSK、Mayne Pharma、Abbott ・産業チェーン及び販売チャネル分析 - ブロムヘキシン錠の産業チェーン分析 - ブロムヘキシン錠の原材料 - ブロムヘキシン錠の生産プロセス - ブロムヘキシン錠の販売及びマーケティング - ブロムヘキシン錠の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ブロムヘキシン錠の産業動向 - ブロムヘキシン錠のマーケットドライバー - ブロムヘキシン錠の課題 - ブロムヘキシン錠の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Bromhexine Tablet Market
Due to the COVID-19 pandemic, the global Bromhexine Tablet market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 8mg accounting for % of the Bromhexine Tablet global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Chronic Bronchitis segment is altered to an % CAGR throughout this forecast period.
China Bromhexine Tablet market size is valued at US$ million in 2021, while the US and Europe Bromhexine Tablet are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Bromhexine Tablet landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Bromhexine Tablet include Sanofi, Teva, Boehringer Ingelheim, Novartis, Mylan, GSK, Mayne Pharma and Abbott, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Bromhexine Tablet Scope and Segment
Bromhexine Tablet market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Bromhexine Tablet market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
8mg
Others
Segment by Application
Chronic Bronchitis
Asthma
Other
By Company
Sanofi
Teva
Boehringer Ingelheim
Novartis
Mylan
GSK
Mayne Pharma
Abbott
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Bromhexine Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Bromhexine Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 8mg
1.2.3 Others
1.3 Market by Application
1.3.1 Global Bromhexine Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Chronic Bronchitis
1.3.3 Asthma
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bromhexine Tablet Sales Estimates and Forecasts 2017-2028
2.2 Global Bromhexine Tablet Revenue Estimates and Forecasts 2017-2028
2.3 Global Bromhexine Tablet Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bromhexine Tablet Sales by Region
2.4.1 Global Bromhexine Tablet Sales by Region (2017-2022)
2.4.2 Global Sales Bromhexine Tablet by Region (2023-2028)
2.5 Global Bromhexine Tablet Revenue by Region
2.5.1 Global Bromhexine Tablet Revenue by Region (2017-2022)
2.5.2 Global Bromhexine Tablet Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bromhexine Tablet Sales by Manufacturers
3.1.1 Global Top Bromhexine Tablet Manufacturers by Sales (2017-2022)
3.1.2 Global Bromhexine Tablet Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bromhexine Tablet in 2021
3.2 Global Bromhexine Tablet Revenue by Manufacturers
3.2.1 Global Bromhexine Tablet Revenue by Manufacturers (2017-2022)
3.2.2 Global Bromhexine Tablet Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bromhexine Tablet Revenue in 2021
3.3 Global Bromhexine Tablet Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bromhexine Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bromhexine Tablet Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bromhexine Tablet Sales by Type
4.1.1 Global Bromhexine Tablet Historical Sales by Type (2017-2022)
4.1.2 Global Bromhexine Tablet Forecasted Sales by Type (2023-2028)
4.1.3 Global Bromhexine Tablet Sales Market Share by Type (2017-2028)
4.2 Global Bromhexine Tablet Revenue by Type
4.2.1 Global Bromhexine Tablet Historical Revenue by Type (2017-2022)
4.2.2 Global Bromhexine Tablet Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bromhexine Tablet Revenue Market Share by Type (2017-2028)
4.3 Global Bromhexine Tablet Price by Type
4.3.1 Global Bromhexine Tablet Price by Type (2017-2022)
4.3.2 Global Bromhexine Tablet Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bromhexine Tablet Sales by Application
5.1.1 Global Bromhexine Tablet Historical Sales by Application (2017-2022)
5.1.2 Global Bromhexine Tablet Forecasted Sales by Application (2023-2028)
5.1.3 Global Bromhexine Tablet Sales Market Share by Application (2017-2028)
5.2 Global Bromhexine Tablet Revenue by Application
5.2.1 Global Bromhexine Tablet Historical Revenue by Application (2017-2022)
5.2.2 Global Bromhexine Tablet Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bromhexine Tablet Revenue Market Share by Application (2017-2028)
5.3 Global Bromhexine Tablet Price by Application
5.3.1 Global Bromhexine Tablet Price by Application (2017-2022)
5.3.2 Global Bromhexine Tablet Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bromhexine Tablet Market Size by Type
6.1.1 North America Bromhexine Tablet Sales by Type (2017-2028)
6.1.2 North America Bromhexine Tablet Revenue by Type (2017-2028)
6.2 North America Bromhexine Tablet Market Size by Application
6.2.1 North America Bromhexine Tablet Sales by Application (2017-2028)
6.2.2 North America Bromhexine Tablet Revenue by Application (2017-2028)
6.3 North America Bromhexine Tablet Market Size by Country
6.3.1 North America Bromhexine Tablet Sales by Country (2017-2028)
6.3.2 North America Bromhexine Tablet Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Bromhexine Tablet Market Size by Type
7.1.1 Europe Bromhexine Tablet Sales by Type (2017-2028)
7.1.2 Europe Bromhexine Tablet Revenue by Type (2017-2028)
7.2 Europe Bromhexine Tablet Market Size by Application
7.2.1 Europe Bromhexine Tablet Sales by Application (2017-2028)
7.2.2 Europe Bromhexine Tablet Revenue by Application (2017-2028)
7.3 Europe Bromhexine Tablet Market Size by Country
7.3.1 Europe Bromhexine Tablet Sales by Country (2017-2028)
7.3.2 Europe Bromhexine Tablet Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bromhexine Tablet Market Size by Type
8.1.1 Asia Pacific Bromhexine Tablet Sales by Type (2017-2028)
8.1.2 Asia Pacific Bromhexine Tablet Revenue by Type (2017-2028)
8.2 Asia Pacific Bromhexine Tablet Market Size by Application
8.2.1 Asia Pacific Bromhexine Tablet Sales by Application (2017-2028)
8.2.2 Asia Pacific Bromhexine Tablet Revenue by Application (2017-2028)
8.3 Asia Pacific Bromhexine Tablet Market Size by Region
8.3.1 Asia Pacific Bromhexine Tablet Sales by Region (2017-2028)
8.3.2 Asia Pacific Bromhexine Tablet Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Bromhexine Tablet Market Size by Type
9.1.1 Latin America Bromhexine Tablet Sales by Type (2017-2028)
9.1.2 Latin America Bromhexine Tablet Revenue by Type (2017-2028)
9.2 Latin America Bromhexine Tablet Market Size by Application
9.2.1 Latin America Bromhexine Tablet Sales by Application (2017-2028)
9.2.2 Latin America Bromhexine Tablet Revenue by Application (2017-2028)
9.3 Latin America Bromhexine Tablet Market Size by Country
9.3.1 Latin America Bromhexine Tablet Sales by Country (2017-2028)
9.3.2 Latin America Bromhexine Tablet Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bromhexine Tablet Market Size by Type
10.1.1 Middle East and Africa Bromhexine Tablet Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bromhexine Tablet Revenue by Type (2017-2028)
10.2 Middle East and Africa Bromhexine Tablet Market Size by Application
10.2.1 Middle East and Africa Bromhexine Tablet Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bromhexine Tablet Revenue by Application (2017-2028)
10.3 Middle East and Africa Bromhexine Tablet Market Size by Country
10.3.1 Middle East and Africa Bromhexine Tablet Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bromhexine Tablet Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Bromhexine Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Bromhexine Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Bromhexine Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Bromhexine Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Bromhexine Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Bromhexine Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Bromhexine Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Bromhexine Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Overview
11.5.3 Mylan Bromhexine Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mylan Bromhexine Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Recent Developments
11.6 GSK
11.6.1 GSK Corporation Information
11.6.2 GSK Overview
11.6.3 GSK Bromhexine Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GSK Bromhexine Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GSK Recent Developments
11.7 Mayne Pharma
11.7.1 Mayne Pharma Corporation Information
11.7.2 Mayne Pharma Overview
11.7.3 Mayne Pharma Bromhexine Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mayne Pharma Bromhexine Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mayne Pharma Recent Developments
11.8 Abbott
11.8.1 Abbott Corporation Information
11.8.2 Abbott Overview
11.8.3 Abbott Bromhexine Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Abbott Bromhexine Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Abbott Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bromhexine Tablet Industry Chain Analysis
12.2 Bromhexine Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bromhexine Tablet Production Mode & Process
12.4 Bromhexine Tablet Sales and Marketing
12.4.1 Bromhexine Tablet Sales Channels
12.4.2 Bromhexine Tablet Distributors
12.5 Bromhexine Tablet Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bromhexine Tablet Industry Trends
13.2 Bromhexine Tablet Market Drivers
13.3 Bromhexine Tablet Market Challenges
13.4 Bromhexine Tablet Market Restraints
14 Key Findings in The Global Bromhexine Tablet Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer